An Act amending the act of November 3, 2022 (P.L.2135, No.150), known as the Childhood Blood Lead Test Act, further providing for title of act, for legislative purpose, for definitions, for lead poisoning prevention, assessment and testing, for duties of department and for blood lead assessment and testing coverage.

HB 2041 amends Pennsylvania's Childhood Blood Lead Test Act to require health care practitioners to ensure children receive at least one blood lead test by 12 months of age and a second test by 24 months of age, with additional testing mandated between 24 and 72 months if not tested by age 2. The bill also requires blood lead testing for pregnant women who have at least one identified lead exposure risk factor. It clarifies that health insurance must cover these tests without cost-sharing, as defined in the bill. This law directly affects children under 72 months, pregnant women, and health care providers in Pennsylvania.